Concepedia

Publication | Closed Access

5LBA First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study)

DOI

38

Citations

0

References

2009

Year

Daniel G. Haller, Josep Tabernero, Jean A. Maroun, Filippo de Braud, T.J. Price, Eric Van Cutsem, Micah Hill, Frank Gilberg, Karen Rittweger, Hans‐Joachim Schmoll
European Journal of Cancer Supplements

No additional data available for this publication yet. Check back later!